Related Experiment Video
Updated: Nov 15, 2025
Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
Published on: August 23, 2022
Developmental histology of the portal plate in biliary atresia: observations and implications
Enrico La Pergola1,2, Yoh Zen3, Mark Davenport4
1Department of Paediatric Surgery, Kings College Hospital, Denmark Hill, London, SE5 9RS, UK.
Insights
Cytokeratin 20 (CK20) expression in biliary atresia (BA) ductules is linked to poorer outcomes. This finding suggests CK20 may predict reduced jaundice clearance and native liver survival in BA patients.
Area of Science:
- Hepatology
- Pediatric Surgery
- Gastroenterology
Background:
- Biliary atresia (BA) is characterized by the obliteration of extrahepatic bile ducts.
- Understanding the immunohistochemical profile of remnant bile ductules is crucial for predicting BA outcomes.
Purpose of the Study:
- To correlate immunohistochemical features of remnant biliary ductules at the porta hepatis with clinical features and outcomes in biliary atresia.
- To investigate the expression of cytokeratin 20 (CK20), vimentin, and alpha-smooth muscle actin (aSMA) in BA remnant ductules.
Main Methods:
- Immunohistochemical staining of remnant biliary ductules using anti-CK20, anti-vimentin, and anti-aSMA antibodies.
- Classification of 82 BA cases into syndromic, cystic, CMV IgM+, and isolated BA subgroups.
- Primary outcome measure was clearance of jaundice (bilirubin ≤ 20 μmol/L) after Kasai portoenterostomy (KPE).
Main Results:
- CK20 expression was observed in 49% of cases, with higher prevalence in non-isolated BA subgroups (CMV IgM+ BA: 89%, cystic BA: 100%) compared to isolated BA (36%).
- Vimentin expression was found in 23% of cases, with no significant difference among BA subgroups.
- CK20 expression was associated with a lower rate of jaundice clearance (57% vs. 77% in CK20-negative cases; P=0.04) and a trend towards reduced native liver survival.
Conclusions:
- Cytokeratin 20 (CK20) expression in remnant biliary ductules is associated with reduced clearance of jaundice following Kasai portoenterostomy in biliary atresia.
- CK20 positivity may serve as a predictive marker for poorer outcomes, including a trend towards reduced native liver survival in BA.
- Further research into the role of CK20 in BA pathogenesis and prognosis is warranted.
Purpose:
The key characteristic of biliary atresia (BA) is obliteration of the extrahepatic bile ducts at the level of the porta hepatis. We aimed to relate the immunohistochemical features of remnant biliary ductules at the porta hepatis with clinical features and outcomes.
Methods:
Samples were immunostained with anti-cytokeratin 20 (CK20), vimentin and alpha-smooth muscle actin (aSMA). Primary outcome was set as clearance of jaundice (bilirubin ≤ 20 μmol/L) following Kasai portoenterostomy (KPE).
Results:
Eighty-two cases were classified into syndromic BA (n = 10), cystic BA (n = 7), CMV IgM+ BA (n = 9) and isolated BA (n = 56). CK20 expression was confirmed in 40/82 (49%), and vimentin expression in 19/82 (23%). aSMA was negative in all cases studied. CK20 expression was less common in isolated BA (n = 20/56, 36%) compared to CMV IgM+ BA (n = 8/9, 89%), cystic BA (n = 7/7, 100%) (isolated BA vs non-isolated BA, P = 0.0008). There was no difference in vimentin expression among the sub-groups (isolated BA vs. non-isolated BA; P = 0.39). CoJ was achieved in 52/82 (63%) overall with significant difference depending simply on sub-group [e.g. syndromic BA 9/10 (90%)]. CK20 expression was associated with a diminished rate of CoJ in the entire cohort [CK20+ 32/56 (57%) vs. CK20- 20/26 (77%); P = 0.04]. By contrast no correlation was observed between vimentin expression and CoJ (P = 0.13).
Conclusion:
CK20+ expression was associated with reduced clearance of jaundice in BA and a trend towards reduced native liver survival.
